Next-Generation strategies to combat antimicrobial resistance: Integrating genomics, CRISPR, and novel therapeutics for effective treatment
Aliu Olalekan Olatunji,
No information about this author
Janet Aderonke Olaboye,
No information about this author
Chukwudi Cosmos Maha
No information about this author
et al.
Engineering Science & Technology Journal,
Journal Year:
2024,
Volume and Issue:
5(7), P. 2284 - 2303
Published: July 24, 2024
Antimicrobial
resistance
(AMR)
poses
a
significant
threat
to
global
public
health,
necessitating
innovative
strategies
combat
this
escalating
issue.
This
review
outlines
next-generation
approaches
integrating
genomics,
CRISPR
technology,
and
novel
therapeutics
effectively
address
AMR.
Genomic
techniques
enable
comprehensive
understanding
of
the
genetic
mechanisms
underpinning
resistance,
facilitating
development
targeted
interventions.
By
sequencing
genomes
resistant
pathogens,
researchers
can
identify
genes,
track
their
spread,
predict
emerging
patterns.
CRISPR-Cas
systems
offer
revolutionary
tool
for
combating
AMR
through
precise
genome
editing.
technology
disrupt
restore
antibiotic
sensitivity,
develop
bacteriophage
therapies
that
selectively
target
bacteria.
Moreover,
CRISPR-based
diagnostics
rapid,
accurate
detection
strains,
enhancing
infection
control
measures.
The
advent
therapeutics,
such
as
antimicrobial
peptides,
therapy,
synthetic
biology-derived
compounds,
provides
alternative
treatment
options.
These
bypass
traditional
exhibit
efficacy
against
multi-drug
organisms.
Additionally,
artificial
intelligence
(AI)
machine
learning
with
genomics
accelerate
discovery
new
antibiotics
trends,
optimizing
regimens.
Implementing
these
requires
robust
collaboration,
regulatory
frameworks,
investment
in
research
development.
combining
CRISPR,
we
create
multifaceted
approach
overcome
AMR,
ensuring
effective
treatments
safeguarding
health.
integration
represents
paradigm
shift
strategy,
offering
hope
future
where
infections
be
managed
treated.
Keywords:
Integrating
Genomics,
Resistance,
Therapeutic
Language: Английский
SAS Meets Machine Learning: An Adaptive Framework for Healthcare Data Fusion
Srinivasa Susrutha Kumar Nayudu Ambati
No information about this author
International Journal of Scientific Research in Computer Science Engineering and Information Technology,
Journal Year:
2025,
Volume and Issue:
11(1), P. 1456 - 1465
Published: Feb. 3, 2025
A
Hybrid
Approach
to
Healthcare
Data
Fusion
using
SAS
and
Machine
Learning
presents
a
novel
framework
for
integrating
traditional
SAS-based
data
management
capabilities
with
modern
machine
learning
algorithms
address
the
complex
challenges
of
healthcare
integration.
This
article
introduces
an
adaptive
architecture
that
leverages
SAS's
robust
processing
features
alongside
specialized
models
entity
resolution,
missing
imputation,
quality
assessment.
demonstrates
significant
improvements
in
completeness,
accuracy,
consistency
compared
methods
alone,
particularly
when
handling
heterogeneous
sources,
including
electronic
health
records,
clinical
trials,
medical
device
outputs.
Through
comprehensive
implemented
at
major
hospital
system,
this
showcases
how
hybrid
methodology
effectively
resolves
common
integration
such
as
semantic
inconsistencies,
temporal
misalignment,
variable
while
maintaining
regulatory
compliance.
The
proposed
offers
organizations
scalable,
maintainable
solution
combines
reliability
established
procedures
adaptability
techniques,
establishing
new
paradigm
fusion.
Language: Английский
Revolutionizing Patient Safety: The Economic and Clinical Impact of Artificial Intelligence in Hospitals
Hospitals,
Journal Year:
2024,
Volume and Issue:
1(2), P. 185 - 194
Published: Dec. 12, 2024
Artificial
intelligence
(AI)
has
emerged
as
a
transformative
force
in
enhancing
patient
safety
within
hospital
settings.
This
perspective
explores
the
various
applications
of
AI
improving
outcomes,
including
early
warning
systems,
predictive
analytics,
process
automation,
and
personalized
treatment.
We
also
highlight
economic
benefits
associated
with
implementation,
such
cost
savings
through
reduced
adverse
events
improved
operational
efficiency.
Moreover,
addresses
how
can
enhance
pharmacological
treatments,
optimize
diagnostic
testing,
mitigate
hospital-acquired
infections.
Despite
promising
advancements,
challenges
related
to
data
quality,
ethical
concerns,
clinical
integration
remain.
Future
research
directions
are
proposed
address
these
harness
full
potential
healthcare.
Language: Английский